-
EP2358200
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2358200
| EP2358200 - SUBSTITUTED BICYCLIC AMINES FOR THE TREATMENT OF DIABETES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.04.2015 Database last updated on 12.07.2024 | Most recent event Tooltip | 24.04.2015 | Application deemed to be withdrawn | published on 27.05.2015 [2015/22] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | [N/P] |
| Former [2012/33] | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway NJ 07065-0907 / US | ||
| Former [2011/34] | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | Inventor(s) | 01 /
HE, Jiafang 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US | 02 /
BAWIEC, John 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US | 03 /
LIU, Weiguo 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US | 04 /
LIANG, Gui-Bai 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US | 05 /
YANG, Lihu 126 East Lincoln Avenue Rahway New Jersey 07065-0907 / US | [2011/34] | Representative(s) | Jaap, David Robert Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | [N/P] |
| Former [2011/34] | Jaap, David Robert Merck & Co., Inc. Hertford Road Hoddesdon, Herts EN11 9BU / GB | Application number, filing date | 09826651.3 | 11.11.2009 | [2011/34] | WO2009US63988 | Priority number, date | US20080115161P | 17.11.2008 Original published format: US 115161 P | [2011/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010056717 | Date: | 20.05.2010 | Language: | EN | [2010/20] | Type: | A1 Application with search report | No.: | EP2358200 | Date: | 24.08.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.05.2010 takes the place of the publication of the European patent application. | [2011/34] | Search report(s) | International search report - published on: | US | 20.05.2010 | (Supplementary) European search report - dispatched on: | EP | 16.04.2012 | Classification | IPC: | C07D209/52, C07D401/12, C07D401/14, C07D403/12, C07D409/14, C07D405/14, C07D413/12, C07D413/14, C07D417/12, C07D471/04, A61K31/403, A61P3/10 | [2012/20] | CPC: |
C07D401/12 (EP,US);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P9/10 (EP);
C07D209/52 (EP,US);
C07D403/12 (EP,US);
|
| Former IPC [2011/34] | A01N43/36, A61K31/40 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/34] | Title | German: | SUBSTITUIERTE BIZYKLISCHE AMINE FÜR DIE BEHANDLUNG VON DIABETES | [2011/34] | English: | SUBSTITUTED BICYCLIC AMINES FOR THE TREATMENT OF DIABETES | [2011/34] | French: | AMINES BICYCLIQUES SUBSTITUÉES POUR LE TRAITEMENT DU DIABÈTE | [2011/34] | Entry into regional phase | 17.06.2011 | National basic fee paid | 17.06.2011 | Search fee paid | 17.06.2011 | Designation fee(s) paid | 17.06.2011 | Examination fee paid | Examination procedure | 17.06.2011 | Examination requested [2011/34] | 07.11.2012 | Amendment by applicant (claims and/or description) | 21.01.2013 | Despatch of a communication from the examining division (Time limit: M04) | 28.05.2013 | Reply to a communication from the examining division | 09.07.2014 | Communication of intention to grant the patent | 19.11.2014 | Application deemed to be withdrawn, date of legal effect [2015/22] | 08.01.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2015/22] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.01.2013 | Fees paid | Renewal fee | 07.11.2011 | Renewal fee patent year 03 | 07.11.2012 | Renewal fee patent year 04 | 07.11.2013 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.11.2014 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IA]US2007093521 (BINGGELI ALFRED [CH], et al) [I] 1-13 * claims 1, 26, 27 * [A] 14,15; | [IA]US2008064697 (CHRIST ANDREAS D [CH], et al) [I] 1-13 * claims 1, 25 * * page 1, paragraph [0003] * [A] 14,15 | International search | [Y]US2006287290 (DART MICHAEL J [US], et al); | [Y]US2007032489 (WEINTRAUB PHILIP M [US], et al); | [Y]US2006205718 (BINGGELI ALFRED [CH], et al); | [Y]US7232879 (GALLOWAY JOHN A [US], et al); | [A]WO2007138431 (PFIZER PROD INC [US], et al) | by applicant | WO02060388 | WO0208188 | WO2004019869 | WO2004020409 | WO2004020408 | WO2004066963 | WO9804528 | WO9901423 | WO0039088 | WO0069810 | WO0042026 | WO0059887 | WO0058360 | WO0123420 | WO9728149 | WO03015774 | WO2004076420 | WO2004081001 | US6730690 | WO03104207 | WO2004058741 | US6054587 | US6110903 | US6284748 | US6399782 | US6489476 | US6699871 | WO02076450 | WO03004498 | WO03004496 | EP1258476 | WO02083128 | WO02062764 | WO03000250 | WO03002530 | WO03002531 | WO03002553 | WO03002593 | WO03000180 | WO03082817 | WO03000181 | WO2004007468 | WO2004032836 | WO2004037169 | WO2004043940 | US6335345 | WO0114376 | WO03007887 | US5624941 | WO02076949 | US6028084 | WO9841519 | WO0010968 | WO9902499 | US5532237 | US5292736 | WO03086288 | WO03087037 | WO2004048317 | WO03063781 | WO03075660 | WO03077847 | WO03082190 | WO03082191 | WO2004012671 | WO2004029204 | WO2004040040 | WO0164632 | WO0164633 | WO0164634 | US6294534 | US6350760 | US6376509 | US6410548 | US6458790 | US6472398 | US5837521 | US6699873 | US2002004512 | US2002019523 | US2002137664 | US2003236262 | US2003225060 | US2003092732 | US2003109556 | US2002177151 | US2002187932 | US2003113263 | WO9964002 | WO0074679 | WO0215909 | WO0170708 | WO0170337 | WO0191752 | WO02068387 | WO02068388 | WO02067869 | WO03007949 | WO2004024720 | WO2004089307 | WO2004078716 | WO2004078717 | WO2004037797 | WO0158891 | WO02070511 | WO02079146 | WO03009847 | WO03057671 | WO03068738 | WO03092690 | WO02059095 | WO02059107 | WO02059108 | WO02059117 | WO02085925 | WO03004480 | WO03009850 | WO03013571 | WO03031410 | WO03053927 | WO03061660 | WO03066597 | WO03094918 | WO03099818 | WO2004048345 | WO0218327 | WO02080896 | WO02081443 | WO03066587 | WO02062766 | WO03000663 | WO03000666 | WO03003977 | WO03040107 | WO03040117 | WO03040118 | WO03013509 | WO02079753 | WO02092566 | WO03093234 | WO03095474 | WO03104761 | - POLONSKY, INT. J. OBES. RELAT. METAB. DISORD., (2000), vol. 24, no. 2, pages 29 - 31 | - BUTLER ET AL., DIABETES, (2003), vol. 52, pages 102 - 110 | - CHISHOLM ET AL., AM. J. PHYSIOL ENDOCRINOL METAB., (2002), vol. 283, pages E311 - E317 | - WANG ET AL., JOURNAL OF SURGICAL RESEARCH, (2005), vol. 129, pages 64 - 72 | - ARULMOZHI ET AL., EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, (2006), vol. 28, pages 96 - 108 | - E.S. FORD ET AL., "Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP-III", JAMA, (20020116), vol. 287, no. 3, pages 356 - 359 | - S. CHAKI ET AL., "Recent advances in feeding suppressing agents: potential therapeutic strategy for the treatment of obesity", EXPERT OPIN. THER. PATENTS, (2001), vol. 11, pages 1677 - 1692 | - D. SPANSWICK; K. LEE, "Emerging antiobesity drugs", EXPERT OPIN. EMERGING DRUGS, (2003), vol. 8, pages 217 - 237 | - J.A. FERNANDEZ-LOPEZ ET AL., "Pharmacological Approaches for the Treatment of Obesity", DRUGS, (2002), vol. 62, pages 915 - 944 |